These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 10697567)
1. Expression and relationship between topoisomerase I and II alpha genes in tumor and normal tissues in esophageal, gastric and colon cancers. Kim R; Ohi Y; Inoue H; Toge T Anticancer Res; 1999; 19(6B):5393-8. PubMed ID: 10697567 [TBL] [Abstract][Full Text] [Related]
2. Expression of DNA topoisomerase I and DNA topoisomerase II-alpha in carcinoma of the colon. Staley BE; Samowitz WS; Bronstein IB; Holden JA Mod Pathol; 1999 Apr; 12(4):356-61. PubMed ID: 10229499 [TBL] [Abstract][Full Text] [Related]
3. Selective use of an alternative stop codon and polyadenylation signal within intron sequences leads to a truncated topoisomerase II alpha messenger RNA and protein in human HL-60 leukemia cells selected for resistance to mitoxantrone. Harker WG; Slade DL; Parr RL; Holguin MH Cancer Res; 1995 Nov; 55(21):4962-71. PubMed ID: 7585537 [TBL] [Abstract][Full Text] [Related]
4. Transfection of a human topoisomerase II alpha gene into etoposide-resistant human breast tumor cells sensitizes the cells to etoposide. Asano T; An T; Zwelling LA; Takano H; Fojo AT; Kleinerman ES Oncol Res; 1996; 8(3):101-10. PubMed ID: 8823806 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical study of DNA topoisomerase II in human gastric disorders. Yabuki N; Sasano H; Kato K; Ohara S; Toyota T; Nagura H; Miyaike M; Nozaki N; Kikuchi A Am J Pathol; 1996 Sep; 149(3):997-1007. PubMed ID: 8780403 [TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamics of topoisomerase I inhibition: Western blot determination of topoisomerase I and cleavable complex in patients with upper gastrointestinal malignancies treated with topotecan. Liebes L; Potmesil M; Kim T; Pease D; Buckley M; Fry D; Cho J; Adler H; Dar K; Zeleniuch-Jacquotte A; Hochster H Clin Cancer Res; 1998 Mar; 4(3):545-57. PubMed ID: 9533521 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical staining for DNA topoisomerase I, DNA topoisomerase II-alpha and p53 in gastric carcinomas. Coleman LW; Bronstein IB; Holden JA Anticancer Res; 2001; 21(2A):1167-72. PubMed ID: 11396158 [TBL] [Abstract][Full Text] [Related]
8. Differential immunohistochemical staining for DNA topoisomerase II alpha and beta in human tissues and for DNA topoisomerase II beta in non-Hodgkin's lymphomas. Bauman ME; Holden JA; Brown KA; Harker WG; Perkins SL Mod Pathol; 1997 Mar; 10(3):168-75. PubMed ID: 9071722 [TBL] [Abstract][Full Text] [Related]
9. Topoisomerase II alpha expression in squamous cell carcinomas of the head and neck. Stathopoulos GP; Kapranos N; Manolopoulos L; Papadimitriou C; Adamopoulos G Anticancer Res; 2000; 20(1A):177-82. PubMed ID: 10769652 [TBL] [Abstract][Full Text] [Related]
11. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma. Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954 [TBL] [Abstract][Full Text] [Related]
12. Elevated expression of the ornithine decarboxylase gene in human esophageal cancer. Yoshida M; Hayashi H; Taira M; Isono K Cancer Res; 1992 Dec; 52(23):6671-5. PubMed ID: 1423312 [TBL] [Abstract][Full Text] [Related]
13. DNA topoisomerase IIalpha and -beta expression in human ovarian cancer. Withoff S; van der Zee AG; de Jong S; Hollema H; Smit EF; Mulder NH; de Vries EG Br J Cancer; 1999 Feb; 79(5-6):748-53. PubMed ID: 10070864 [TBL] [Abstract][Full Text] [Related]
14. Structural and functional analysis of the control region of the human DNA topoisomerase II alpha gene in drug-resistant cells. Takano H; Ise T; Nomoto M; Kato K; Murakami T; Ohmori H; Imamura T; Nagatani G; Okamoto T; Ohta R; Furukawa M; Shibao K; Izumi H; Kuwano M; Kohno K Anticancer Drug Des; 1999 Apr; 14(2):87-92. PubMed ID: 10405635 [TBL] [Abstract][Full Text] [Related]
15. Factors contributing to adriamycin sensitivity in human xenograft tumors: the relationship between expression of the MDR1, GST-pi and topoisomerase II genes and tumor sensitivity to adriamycin. Kim R; Hirabayashi N; Nishiyama M; Jinushi K; Toge T; Okada K Anticancer Res; 1992; 12(1):241-5. PubMed ID: 1314532 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of topoisomerase IIalpha expression by transforming growth factor-beta1 is abrogated by the papillomavirus E7 protein. Satterwhite DJ; White RL; Matsunami N; Neufeld KL Cancer Res; 2000 Dec; 60(24):6989-94. PubMed ID: 11156401 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical and two-parameter flow cytometric studies of DNA topoisomerase II alpha in human epithelial ovarian carcinoma and germ cell tumor. Tanoguchi K; Sasano H; Yabuki N; Kikuchi A; Ito K; Sato S; Yajima A Mod Pathol; 1998 Feb; 11(2):186-93. PubMed ID: 9504690 [TBL] [Abstract][Full Text] [Related]
18. Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables. Depowski PL; Rosenthal SI; Brien TP; Stylos S; Johnson RL; Ross JS Mod Pathol; 2000 May; 13(5):542-7. PubMed ID: 10824926 [TBL] [Abstract][Full Text] [Related]
19. DNA topoisomerase II-alpha as a proliferation marker in astrocytic neoplasms of the central nervous system: correlation with MIB1 expression and patient survival. Holden JA; Townsend JJ Mod Pathol; 1999 Dec; 12(12):1094-100. PubMed ID: 10619260 [TBL] [Abstract][Full Text] [Related]
20. Topoisomerase II-alpha expression in different cell cycle phases in fresh human breast carcinomas. Villman K; Ståhl E; Liljegren G; Tidefelt U; Karlsson MG Mod Pathol; 2002 May; 15(5):486-91. PubMed ID: 12011253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]